Commercial Medical Devices

MHRA Opens Community of Practice for Digital Mental Health Technologies

The UK regulator has created a forum and survey to clarify evidence and compliance expectations for software-based mental health tools.

Talia ReinerOctober 22, 20265 min read11 views
A conceptual editorial scene showing a digital therapeutic device linked to a regulatory review structure, with non-identifiable figures gathered around a shared table.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced a new Community of Practice for Digital Mental Health Technologies, according to an update on its official blog. The initiative is intended to strengthen regulatory understanding and provide practical support to developers in a fast-growing area of UK medtech.

The community will bring together developers, clinicians, researchers, commissioners and regulatory specialists. Its stated objectives include helping developers interpret regulatory requirements and build compliance into product design earlier, identifying common challenges for innovators—particularly small and medium-sized enterprises entering the mental health space—and sharing real-world experience from organisations already working through regulatory pathways.

The MHRA also says the forum is meant to improve dialogue between industry and regulators so that emerging technologies can meet expectations for safety, performance and evidence. The announcement points to growing demand for clarity on evidence requirements, post-market responsibilities and the regulatory landscape for software-based and AI-enabled mental health tools.

To help set the community’s initial priorities, the MHRA has opened a survey for developers and other stakeholders across the medtech ecosystem. The survey asks about current regulatory challenges, where clearer guidance is needed and how compliance support could be improved. The agency is encouraging broad participation so that the community reflects practical needs rather than top-down assumptions.

The MHRA says developers can use the survey to influence future regulatory support and help create a more predictable and transparent environment for innovation. It is encouraging recipients to complete the survey and share it within their organisations.